moxifloxacin

Ukraine

Drugs containing this active substance

  • ATOVAX

    The drug is prescribed for the treatment of acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs of mild to moderate severity in adults.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: KUSUM FARM LLC

  • The drug is used to treat bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Bayer AG (entire production cycle (production of unpackaged products, primary packaging, secondary packaging, quality control, batch release))

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues. It should be used only when other antibacterial agents recommended for initial treatment are inappropriate.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: Bayer AG (batch release)

  • The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: Vioser S.A. Parenteral Solutions Industries (unpacked product, primary packaging, secondary packaging, control)

  • The drug is used for the topical treatment of bacterial conjunctivitis caused by bacteria sensitive to it.

    Form: drops, ophthalmic

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Farmak JSC

  • The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: JSC "Farmak" (full production cycle)

  • The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic bronchitis, non-hospital pneumonia, and moderate to severe inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Sunshine Lake Pharma Co., Ltd.

  • The drug is intended for the treatment of community-acquired pneumonia, as well as complicated skin and soft tissue infections.

    Form: concentrate for infusion solution

    Active substance Dosage
    moxifloxacin 20 mg/ml

    ATC: J01MA14

    Manufacturer: Yuria-Pharm LLC

  • The drug is indicated for the treatment of non-hospital pneumonia, as well as complicated infections of the skin and soft tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 1.6 mg/ml

    ATC: J01MA14

    Manufacturer: Yuria-Pharm LLC

  • The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: ANFARM HELLAS S.A.

  • The drug is prescribed for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs (under certain conditions).

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: KRKA, d.d., Novo Mesto (responsible for full manufacturing cycle, including batch release)/KRKA, d.d., Novo Mesto (responsible for batch control)

  • The drug is used for the treatment of community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 1.6 mg/ml

    ATC: J01MA14

    Manufacturer: KRKA, d.d., Novo Mesto (manufacturing 'in bulk', primary and secondary packaging, batch control and batch release)/KRKA, d.d., Novo Mesto (batch control)

  • The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic bronchitis, non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Torrent Pharmaceuticals Ltd

  • The drug is used for the local treatment of bacterial conjunctivitis caused by bacterial strains sensitive to it.

    Form: drops, ophthalmic solution

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Pharmar Anonymous Industrial Single Member Company of Pharmaceuticals and Cosmetics (manufacturer "in bulk", packaging and batch control)

  • The drug is used for the local treatment of bacterial conjunctivitis caused by bacteria sensitive to it.

    Form: drops, ophthalmic solution

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Jadran-Galenski Laboratorij d.d.

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: ANFARM HELLAS S.A.

  • The drug is used for the local treatment of bacterial conjunctivitis caused by bacteria sensitive to it.

    Form: drops, ophthalmic

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Indoco Remedies Limited

  • The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Hetero Labs Limited

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: PJSC "Infuziya"

  • The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and mild to moderate pelvic inflammatory diseases.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: PJSC "Tekhnolog"

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: Subsidiary Enterprise "Farmatreyd"

  • The drug is prescribed for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, moderate to severe pelvic inflammatory diseases, as well as complicated skin and subcutaneous tissue infections.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: PJSC "Kyivmedpreparat"

  • The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: PJSC "Halychpharm"

  • The drug is used to treat bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), community-acquired pneumonia, and mild to moderate pelvic inflammatory diseases. It can also be used to complete a course of treatment after intravenous administration for community-acquired pneumonia or complicated skin infections.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: ASTRAFARM LLC

  • The drug is prescribed to adults for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs. It can also be used to complete a course of treatment following intravenous injections for pneumonia or complicated skin infections.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: JSC "Lubnipharm"

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: VEM Ilac San. ve Tik. A.S.

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and skin appendages.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is prescribed for the treatment of bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Farmex Group LLC

  • The drug is used for the topical treatment of bacterial conjunctivitis caused by bacterial strains sensitive to it.

    Form: drops, ophthalmic

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Farmex Group LLC

  • The drug is prescribed for the treatment of non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: JSC FARMATEN

  • The drug is used to treat bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), community-acquired pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: Subsidiary Enterprise "Farmatreyd"

  • The drug is prescribed for the treatment of bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and moderate to severe inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Macleods Pharmaceuticals Limited

  • The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic bronchitis, non-hospital pneumonia, and mild to moderate pelvic inflammatory diseases.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Bafna Pharmaceuticals Ltd.

  • The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

    Form: solution for infusion

    Active substance Dosage
    moxifloxacin 400 mg/250 ml

    ATC: J01MA14

    Manufacturer: Evrolife Healthcare Pvt. Ltd.

  • The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Aurobindo Pharma Limited – Unit VII

  • The drug is used for the topical treatment of bacterial conjunctivitis caused by bacteria sensitive to it.

    Form: drops, ophthalmic

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Farmaten S.A. (secondary packaging, quality control and batch release)

  • The drug is prescribed for the treatment of bacterial infections in adults (from 18 years old), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and moderate to severe inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: ALKALOID AD Skopje

  • The drug is used to treat bacterial infections in adults (from 18 years old), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

    Form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

    Manufacturer: Rivopharm SA

  • The drug is used for the topical treatment of bacterial conjunctivitis caused by bacteria sensitive to it.

    Form: drops, ophthalmic

    Active substance Dosage
    moxifloxacin 5 mg/ml

    ATC: S01AE07

    Manufacturer: Alcon Coutier